Symproic (Naldemedine)

Naldemedine · Shionogi & Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Symproic (Naldemedine), covering 2025-04-20 to 2025-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids [Phase 1, Phase 2]